Halliburton (HAL) Incurs Narrower-than-Expected Q2 Loss

HAL

Houston, Texas-based Halliburton Company (HAL - Free Report) is one of the largest oilfield service providers in the world, offering a variety of equipment, maintenance, and engineering and construction services to the energy, industrial, and government sectors.

Currently, Halliburton has a Zacks Rank #3 (Hold) but that could change following its second-quarter 2016 results which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: The company reported loss per share from continuing operations − excluding special items − of 14 cents, narrower than the Zacks Consensus Estimate of loss of 19 cents. 

Revenue: Revenues of $3,835 million has surpassed the Zacks Consensus Estimate of $3,744 million. 

Key Stats: Operating loss from the Completion & Production segment was $32 million, against a profit of $313 million in the year-ago quarter. From the Drilling & Evaluation unit, Halliburton generated income of $154 million, decreased 61.5% from $400 million in the prior year comparable period.   

Check back later for our full write up on this Halliburton earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>